Cite
MLA Citation
Alessandra Fabi et al.. “Eribulin in heavily pretreated metastatic breast cancer patients and clinical/biological feature correlations: impact on the practice.” Future oncology, vol. 11, 2015, pp. 431–438. http://access.bl.uk/ark:/81055/vdc_100146743486.0x000020